Christopher B.Anderson (Chris)

Partner

Chicago + 1.312.269.1552

Connect:

Share

Chris Anderson is a health care regulatory and transactional attorney who counsels industry clients on the development of strategic partnerships and initiatives designed to create synergies, advance quality, foster efficiencies, and further align providers. He works with private equity funds, strategic investors, institutional and professional health care providers, telehealth/health tech companies, and life science companies on strategic, transactional, and regulatory matters affecting these industries.

Chris regularly represents private equity funds and other strategics in evaluating targets, structuring investment opportunities and divestitures, and mitigating risks in the health care space. His hospital-physician integration experience encompasses mergers, acquisitions, and affiliations of health systems, ASCs, large physician groups, and other ancillary providers, as well as the formation of care coordination entities, joint ventures, pay-for-performance and gain sharing programs, co-management agreements, ACOs, clinically integrated networks, and other partnership opportunities. He has structured innovative arrangements between for-profit entities and nonprofit providers and/or quasi-governmental entities, leading to the preservation of community health care assets while creating value for investors.

Chris's regulatory practice includes advising clients on various fraud and abuse and self-referral matters, HIPAA and other data security compliance issues, and Medicare program requirements as well as state licensure, certificate of need, corporate practice of medicine, and fee-split problems.

Chris is on the board of directors of the Illinois Association of Healthcare Attorneys and is a member of the American Health Lawyers Association. He has written and spoken extensively on the applications of health care law and is an adjunct professor at the University of Illinois-Chicago.

Experience

  • Associated Urological Specialists sold to Solaris Health Holdings, LLCJones Day advised Associated Urological Specialists, LLC, a large Chicago-based physician group specializing in comprehensive urologic care, including radiation oncology, pathology, and pharmacy, in its sale to Solaris Health Holdings, LLC, a leading national urology platform backed by Lee Equity Partners.
  • Digital health companies, specialty hospitals, and health systems maintain compliance with multistate requirements through 50-state surveyJones Day is representing digital health companies, specialty hospitals, and health systems in maintaining compliance with multistate requirements through a regularly updated, extensive 50-state survey on state laws and regulations applicable to telehealth activities of physicians and other health care professionals including licensing, establishing patient relationships, provider-to-provider consulting, supervision and delegation among providers, and prescribing and treatment standards.
  • Riverside portfolio company acquires CordicoJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Lexipol, LLC of Cordico, a provider of purpose-built, mobile health and wellness applications that deliver high-quality wellness tools, resources and assessments to public safety customers including law enforcement, fire, EMS, corrections, and more.
  • Astellas Pharma acquires iota BiosciencesJones Day advised Astellas Pharma Inc. in its acquisition of iota Biosciences.
  • Integrated Medical Professionals sold to Lee Equity PartnersJones Day advised Integrated Medical Professionals, PLLC, a multi-specialty physician group specializing in urology, radiation oncology, and pathology, in its acquisition by Lee Equity Partners.
  • GM partners with Ventec to manufacture ventilators in response to coronavirus pandemicJones Day is advising General Motors Company on the "Project V" partnership with Ventec Life Systems Inc. to mass produce ventilators needed to battle the coronavirus pandemic.
  • Concord Health Partners participates in $25 million investment in Pieces TechnologiesJones Day represented Concord Health Partners LLC in connection with their investment in Pieces Technologies, a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health.
  • DataBank acquires LightBoundJones Day advised DataBank in connection with the acquisition and related financing of LightBound, an Indianapolis-based provider of colocation, Internet, voice, network, and cloud services.
  • Concord Health Partners invests in VitalTech™Jones Day represented Concord Health Partners LLC in connection with its purchase of Series A Convertible Preferred Stock in a private placement by VitalTech™, a provider of connected health and remote patient monitoring services.
  • Hill-Rom sells surgical consumable products to Audax Private Equity for $170 millionJones Day advised Hill-Rom Holdings, Inc. (NYSE: HRC), which recently rebranded as Hillrom, in its $170 million sale of certain surgical consumable products and related assets to an affiliate of Audax Private Equity.
  • Riverside acquires Champion Healthcare TechnologiesJones Day represented The Riverside Company in connection with the acquisition and related financings of Champion Healthcare Technologies, a SaaS provider that enables hospitals to manage surgical implants throughout their life cycle.
  • Healthcare administration company obtains closure of U.S. Department of Labor criminal inquiryJones Day obtained a declination to prosecute by the U.S. Department of Labor – Criminal Division in an ERISA investigation against a healthcare administration company.

    • The following represents experience acquired prior to joining Jones Day.

    Hospitals

    Represented a for-profit hospital acquisition company in acquiring two community hospitals and in establishing new programs.

    Represented a community hospital in the sale of substantially all of its assets to and the establishment of a joint venture with a publically traded hospital management company.

    Represented a tax-exempt nonprofit hospital in a membership substitution transaction with a large academic medical center.

    Represented a critical access hospital in a membership substitution transaction with a regional health system.

    Represented a regional health systems in connection with the purchase of certain assets and the negotiation of an exclusive hospital professional services contract.

    Physician Practice Management

    Advised on physician practice acquisitions and divestitures, including structuring "captive practice" arrangements and developing compensation models and structuring other financial arrangements for the practices going forward.

    Advised on acquisitions and sales of physician practices and practice management services organizations (MSOs) to and by private equity funds and strategic operators, including dermatology, ophthalmology, gastroenterology, and primary care practices.

    Ambulatory Surgical Centers

    Represented physician practices, strategics, and private equity funds in connection with acquisitions and sales of ambulatory surgical center companies or other companies with ambulatory surgical center lines of business.

    Digital Health

    Represented various start-ups in development, capitalization, compliance, and sale of telehealth and data mining enterprises.

    Proton Therapy

    Represented leading health system in the restructure and recapitalization of a multifaceted proton therapy joint venture.

    Represented a large health systems in the development of a proton therapy venture.

    Other Health Care Experience

    Represented providers, including hospitals, physician practices, ambulatory surgery centers, diagnostic imaging facility operators, and others in connection with joint ventures, under arrangements and other affiliation transactions.

    Represented various hospitals and health systems in the formation of clinically integrated networks, including establishment of a statewide multisystem clinically integrated network.

    Represented a children's hospital in the establishment of a multi-provider, multi-insurer care coordination program.

    Represented various providers, suppliers, device manufacturers, and pharmaceutical companies with respect to fraud and abuse laws and other regulatory matters.

    View All

    April 2021 Newsletters

    Vital Signs: Digital Health Law Update Spring 2021

    January 2021 Newsletters

    Vital Signs Digital Health Law Update Winter 2021

    October 2020 Newsletters

    Vital Signs: Digital Health Law Update | Fall 2020

    July 2020 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2020

    January 2020 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2020

    February 2018 Commentaries

    DOJ Pursues PE Firm Based on Portfolio Company's Alleged Payment of Kickbacks

    Speaking Engagements

    • April 2018
      Jones Day 2018 Health Care and Life Science Forum "Digital Health and Investors: Changing Delivery of Health Care, One Device at a Time"
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.